OpenVSafe by OpenVAERS
Search V-safe

DKR-25617-10279

3 vaccinations 6 coded responses 24 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
05-11
ZIP prefix
100 / NY
Registered
2022-06-30
Relationship
Child or adolescent in my care
Guardian
34Z-38493-37155
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-29
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-30
    Registered in v-safe
  3. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Fair · Site: Pain · Fever · None
    Adult check-in
  4. 2022-07-02
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2022-07-03
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2022-07-04
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-07-05
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-07-06
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-07-13
    Survey response — day 14, dose 1, dependent
    MedDRA: Cough — Feeling: Fair
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-07-20
    Health check-in — day 21, dose 1, dependent
    Feeling: Good
    Adult check-in
  11. 2022-07-27
    Dose 2 — Pfizer-BioNTech
  12. 2022-07-27
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2022-07-30
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  14. 2022-08-03
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  15. 2022-08-31
    Survey response — day 35, dose 2, dependent
    MedDRA: Eczema — Feeling: Good
    Free text: New eczema patches on neck and inside of elbows
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-09-07
    Survey response — day 42, dose 2, dependent
    MedDRA: Eczema — Feeling: Good
    Free text: Eczema
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-10-26
  18. 2022-11-04
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  19. 2022-11-04
    Health check-in — day 0, dose 3, dependent
    Feeling: Fair · Site: Pain, Swelling · Fever · None
    Adult check-in
  20. 2022-11-05
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  21. 2022-11-06
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  22. 2022-11-08
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  23. 2022-11-13
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  24. 2022-11-25
    Survey response — day 21, dose 3, dependent
    MedDRA: Pyrexia, Vomiting — Feeling: Good · Be unable to work or attend school
    Free text: Fever, vomiting
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-12-09
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  26. 2022-12-22
    Survey response — day 42, dose 3, dependent
    MedDRA: Cough, Diarrhoea, Pyrexia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Fever, cough, diarrhea
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-12-22
    Report sent to call center — day 42, dose 3, dependent
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-12-23
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  29. 2023-02-03
    Survey response — 3 months, dose 3, dependent
    MedDRA: Cough — Feeling: Good
    MedDRA releases: 2024-11
  30. 2023-05-07

Vaccinations

DoseDateManufacturerCo-administered
12022-06-29Pfizer-BioNTech No
22022-07-27Pfizer-BioNTech No
32022-11-04Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 — day 14, dose 1, dependent

2022-07-13

Symptoms: Cough

Release 12 — day 35, dose 2, dependent

2022-08-31

Symptoms: New eczema patches on neck and inside of elbows

Release 12 — day 42, dose 2, dependent

2022-09-07

Symptoms: Eczema

Release 12 — day 21, dose 3, dependent

2022-11-25

Symptoms: Fever, vomiting

Release 12 — day 42, dose 3, dependent

2022-12-22

Symptoms: Fever, cough, diarrhea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDiarrhoea · · ✓
SDEczema · · ✓
SDPyrexia · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release